Objective. To evaluate various endometrial pathologies described in association with
postmenopausal tamoxifen treatment, as well as the clinical aspects of these endometrial …

The critical step in the development of novel approaches to prevent disease is the
translation of laboratory concepts to clinically useful interventions. The expanding database …

OBJECTIVES: In a RCT, we have previously shown that the levonorgestrel intrauterine
system (LNG-IUS, Mirena®) produces a decidual response protecting the endometrium at …

Objective: To evaluate immunohistochemical, hysteroscopic, and histological findings in
postmenopausal women taking tamoxifen for breast cancer. Methods: Forty postmenopausal …

Introduction: breast cancer is the cancer with the highest incidence in women in Brazil,
representing 29.7% of all cancers. More than two thirds of women with breast cancer show …

OBJECTIVE.: A prospective evaluation of the effects on endometrium of third generation
aromatase inhibitors (AIs), administered as adjuvant up-front therapy or switched therapy in …

OBJECTIVES: To estimate the pretreatment incidence of endometrial pathology and to
prospectively assess the endometrial morbidity emerging during tamoxifen intake for breast …

OBJECTIVE.: The aim of this study is to estimate the prevalence of endometrial pathology
before the start of tamoxifen therapy in menopausal breast cancer patients. METHODS …

Objective To evaluate the prevalence of endometrial polyps in obese asymptomatic pre and
postmenopausal patients with breast cancer and to know if a baseline pretamoxifen …

Introduction: The aim of this study was to evaluate endometrial changes after five years of
tamoxifen treatment by measuring endometrial thickness with transvaginal ultrasonography …